Alibasa, Johana T.

HRN: 23-91-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
CEFUROXIME 500MG (TAB)
08/14/2025
08/21/2025
PO
1 Tab
Q12h
S/P NSVD
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: